SEC Comment Letter for MIV THERAPEUTICS INC (CIK 0001083011) — Dec 1, 2005
MIV THERAPEUTICS INC (CIK 0001083011)
Date: Dec. 1, 2005 · CIK: 0001083011 · Accession: 0000000000-05-060328
AI Filing Summary & Sentiment
File numbers found in text: 000-30453
Letter
Mail Stop 6010 December 1, 2005 Mr. Patrick McGowan Chief Financial Officer MIV Therapeutics, Inc. 1-8765 Ash Street Vancouver, B.C. Canada V6P 6T3
Re: MIV Therapeutics, Inc. Form 10-KSB/A for the fiscal year ended May 31, 2004 File No. 000-30453
Dear Mr. McGowan:
We have completed our review of your Form 10-KSB and related filings and do not, at this time, have any further comments.
Sincerely,
Martin F. James
Senior Assistant Chief
Accountant
Show Raw Text
<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
Mail Stop 6010
December 1, 2005
Mr. Patrick McGowan
Chief Financial Officer
MIV Therapeutics, Inc.
1-8765 Ash Street
Vancouver, B.C. Canada V6P 6T3
Re: MIV Therapeutics, Inc.
Form 10-KSB/A for the fiscal year ended May 31, 2004
File No. 000-30453
Dear Mr. McGowan:
We have completed our review of your Form 10-KSB and related
filings and do not, at this time, have any further comments.
Sincerely,
Martin F. James
Senior Assistant Chief
Accountant
</TEXT>
</DOCUMENT>